Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Chenhao Li"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Basic Research
Article image
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
Lili Kong, Hongyue Wang, Chenhao Li, Huiyan Cheng, Yan Cui, Li Liu, Ying Zhao
Diabetes Metab J. 2021;45(6):909-920.   Published online June 4, 2021
DOI: https://doi.org/10.4093/dmj.2020.0168
  • 11,278 View
  • 169 Download
  • 36 Web of Science
  • 40 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Background
The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis.
Methods
Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis.
Results
SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro.
Conclusion
Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.

Citations

Citations to this article as recorded by  
  • Hydroalcoholic extract of Benincasa hispida (Thunb.) Cogn. reinstates renal structural and functional dynamics compromised in diabetic mice: molecular insights through integration of transcriptomics and proteomics
    Nivedita Singh, Anuradha Kesharwani, Rahul Laxman Gajbhiye, Harsha Sankar Sreenikethanam Hari, Ruthrotha Selvi Bharathavikru, Velayutham Ravichandiran, Vipan Kumar Parihar
    Journal of Ethnopharmacology.2026; 362: 121132.     CrossRef
  • Beyond hyperglycemia: histone modification-mediated epigenetic dysregulation in diabetic retinopathy and nephropathy
    Minxuan Tang, Hongyu Zhu, Suyan Li, Lei Qiao
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • The Role of Protein Post-Translational Modifications in the Pathogenesis of Nephrolithiasis: Mechanistic Insights and Translational Potential
    Wenlong Wan, Baokang Wang, Junyi Yang, Yang Xun, Xiao Yu
    Cells.2026; 15(6): 554.     CrossRef
  • Dietary and nutritional interventions for human diseases: their modulatory effects on ferroptosis
    Shiqiong Huang, Ji Sun, Chaozan Shen, Gefei He
    Food & Function.2025; 16(4): 1186.     CrossRef
  • Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes
    Imari Mimura, Zhuo Chen, Rama Natarajan
    Kidney International.2025; 107(3): 434.     CrossRef
  • Protective role of sulforaphane in lipid metabolism-related diseases
    Lingfeng Zhao, Jiahuan Li, Yiping Dang, David Fisher, Nguyen Thi Thu Hien, Erkin Musabaev, Khrystyna Pronyuk, Lei Zhao
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Histone deacetylases and their inhibitors in kidney diseases
    Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du
    Molecular Therapy.2025; 33(8): 3485.     CrossRef
  • Investigating potential targets of Wulingsan in diabetic nephropathy through network pharmacology and experimental validation
    Xicheng Hu, Zhen Wang, Liyan Zhang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Chidamide, a novel histone deacetylase inhibitor, alleviates renal fibrosis by suppressing the PI3K/AKT signaling pathway
    Yumei Liu, Liwen Mao, Yanbing Tang, Xiaowen Huang, Cunjin Su, Ye Zhu, Qianqian Duan, Kai Song, Jie Pan, Zhanhong Hu
    Biochemical Pharmacology.2025; 240: 117098.     CrossRef
  • Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases
    Sunyoung Jang, Nayun Choi, Jong Hoon Park, Kyung Hyun Yoo
    BMB Reports.2025; 58(8): 313.     CrossRef
  • Acetylation in renal physiology and pathophysiology
    Jian-Yu Zhang, Jun Wu, Zi-Han Chen, Shi-Yue Liu, Ping Li, Dan-Qian Chen
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Sulforaphane from broccoli, an epigenetic modulator in cancer cells
    Soayébo Dabre, Abdou Azaque Zoure, Lassina Barro, Jeanne d’Arc Wendmintiri Kabre, Mousso Savadogo, Aida Dje Traore, Florencia Djigma, Jacques Simpore
    Discover Oncology.2025;[Epub]     CrossRef
  • Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance
    Minlong Wei, Jinyun Lin, Yi Zeng, Xiaojuan Wang, Jialu Wen, Jing Wang, Wei Zou, Kang Tu, Menghua Liu, Juan Li
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration
    Muhammad Javid Iqbal, Luis A. Salazar
    Frontiers in Epigenetics and Epigenomics.2025;[Epub]     CrossRef
  • Glucosinolates Hydrolysis Products: Promising Bioactives for the Prevention of Diabetes
    Rohini Bhat, Sugandh Saxena, Manu Khajuria, Dhiraj Vyas
    Molecular Nutrition & Food Research.2025;[Epub]     CrossRef
  • Pharmacological Modulation of the Nrf2–Keap1 Pathway in Diabetes: Mechanisms, Therapeutic Advances, and Future Directions
    Amar Saxena, Shrestha Saxena, Yash Saxena, Ashita Jain, Rama Chaudhary, Pooja Bharti, Shivdeep Mishra, Chandrabhan Singh, Abhishek Kumar, Ankit Kumar, Sanjeev Kumar
    Journal for Research in Applied Sciences and Biotechnology.2025; 4(5): 38.     CrossRef
  • Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
    Tao Jiang, Yuhe Dong, Wanying Zhu, Tong Wu, Linyan Chen, Yuantong Cao, Xi Yu, Ye Peng, Ling Wang, Ying Xiao, Tian Zhong
    Critical Reviews in Food Science and Nutrition.2024; 64(31): 11543.     CrossRef
  • Sulforaphane reduces adipose tissue fibrosis via promoting M2 macrophages polarization in HFD fed-mice
    Zhenzhen Zhang, Huali Chen, Cheng Pan, Rui Li, Wangsheng Zhao, Tianzeng Song
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119626.     CrossRef
  • Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
    Patrícia dos Santos Azeredo, Daping Fan, E. Angela Murphy, Wayne E. Carver
    Cells.2024; 13(5): 421.     CrossRef
  • Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes
    Katarina Zeder, Edward D. Siew, Gabor Kovacs, Evan L. Brittain, Bradley A. Maron
    Nature Reviews Nephrology.2024; 20(11): 742.     CrossRef
  • Role of Histone Modifications in Kidney Fibrosis
    Shengyu Pan, Tianhui Yuan, Yuqi Xia, Weimin Yu, Xiangjun Zhou, Fan Cheng
    Medicina.2024; 60(6): 888.     CrossRef
  • Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation
    Yanan Wang, Xiaoyun He, Nan Cheng, Kunlun Huang
    Nutrients.2024; 16(12): 1877.     CrossRef
  • Nonsurgical therapy for lumbar spinal stenosis caused by ligamentum flavum hypertrophy: A review
    Nan Fang, Zhigang Wang, Jiecheng Jiang, Aofei Yang, Tian Mao, Zitong Wang, Qian Chen
    Medicine.2024; 103(27): e38782.     CrossRef
  • Sulforaphane alleviates renal fibrosis through dual regulation on mTOR-mediated autophagy pathway
    Di Zhang, Han Zhang, Shiqi Lv, Cheng Zhu, Shaomin Gong, Xixi Yu, Yulin Wang, Xinhui Huang, ShuangXin Yuan, Xiaoqiang Ding, Xiaoyan Zhang
    International Urology and Nephrology.2024; 57(4): 1277.     CrossRef
  • Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes
    Aminu Mohammed, Hafsat Abdullahi Mohammed
    Phytomedicine Plus.2023; 3(2): 100431.     CrossRef
  • The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
    Christodoula Kourtidou, Konstantinos Tziomalos
    International Journal of Molecular Sciences.2023; 24(6): 6007.     CrossRef
  • Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
    Da-Wei Lin, Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Chun-Liang Lin
    International Journal of Molecular Sciences.2023; 24(7): 6053.     CrossRef
  • Beneficial Effects of Sulforaphane on Diabetes and Its Complications via Both Nrf2-Dependent and Independent Mechanisms
    Minhyuk Kim, Joo Young Lee
    Food Supplements and Biomaterials for Health.2023;[Epub]     CrossRef
  • Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis
    Elisa B. Monteiro, Matheus Ajackson, Milena B. Stockler-Pinto, Fitsum Guebre-Egziabher, Julio B. Daleprane, Christophe O. Soulage
    Life Sciences.2023; 322: 121664.     CrossRef
  • Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway
    Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
    Chemico-Biological Interactions.2023; 382: 110559.     CrossRef
  • Sulforaphane: A nutraceutical against diabetes-related complications
    Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano, Phiwayinkosi V. Dludla
    Pharmacological Research.2023; 196: 106918.     CrossRef
  • Nrf2/HO-1 as a therapeutic target in renal fibrosis
    Emad H.M. Hassanein, Islam M. Ibrahim, Esraa K. Abd-alhameed, Zeina W. Sharawi, Fatima A. Jaber, Hanan S. Althagafy
    Life Sciences.2023; 334: 122209.     CrossRef
  • A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications
    Neda Mohamadi, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Fatemeh Sharifi, Vahid Reza Askari
    Inflammopharmacology.2023; 31(6): 2885.     CrossRef
  • The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease
    Zongji Zheng, Shuting Zhang, Jiaqi Chen, Meina Zou, Yanlin Yang, Wen Lu, Shijing Ren, Xiangyu Wang, Wenhui Dong, Zikun Zhang, Ling Wang, Meiping Guan, Gladys L.Y. Cheing, Yaoming Xue, Yijie Jia
    Clinical Science.2022; 136(3): 223.     CrossRef
  • BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
    Yawen Xiao, Dan Liang, Zhiyang Li, Zhaowei Feng, Zhiping Yuan, Fan Zhang, Yuanyuan Wang, Yuxia Zhou, Mingjun Shi, Lingling Liu, Ying Xiao, Bing Guo
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation
    Chun Ouyang, Lei Huang, Xiaoqiang Ye, Mingming Ren, Zhen Han
    Experimental and Clinical Endocrinology & Diabetes.2022; 130(10): 660.     CrossRef
  • Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
    Jialu Li, Chao Yu, Fengchen Shen, Binbin Cui, Na Liu, Shougang Zhuang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
    Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu, Hang Yin
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
    Mengjiao Wang, Min Chen, Rui Guo, Yangyang Ding, Haihui Zhang, Yuanqing He
    Trends in Food Science & Technology.2022; 129: 397.     CrossRef
  • Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
    Hao Yan, Jiangxin Xu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He
    Biomedicine & Pharmacotherapy.2021; 143: 112115.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP